Please provide your email address to receive an email when new articles are posted on . Further, those with both low FEV 1 /FVC ratio and low FVC trajectories — which researchers defined as a “mixed” ...

Having low lung function as a middle-aged smoker without airway obstruction raised the likelihood for all-cause mortality, ...

Hypercapnic patients were best separated from normocapnic patients using thresholds for FVC% of 56% predicted and 33% predicted for FEV1%. Hypercapnia in patients with chronic obstructive pulmonary ...

A recent study published in the journal of Radiology showed that dynamic chest radiography (DCR) may serve as an effective ...

The U.S. Food and Drug Administration has approved Jascayd (nerandomilast) tablets for the treatment of progressive pulmonary ...

Here are the top 5 most-read pulmonary fibrosis articles of 2025.

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

Remote patient monitoring of patients with COPD can offer clues about what happens before an exacerbation. While telemedicine and remote patient monitoring (RPM) have potential for proactive ...

Bexotegrast-treated patients demonstrated improvements in forced vital capacity (FVC) and reduced cough severity compared to placebo. Bexotegrast was well tolerated at 160 mg over 12 weeks of ...

Supported by an independent educational grant from Boehringer Ingelheim and Pfizer. Mrs. Sweet is a 51-year-old woman who presents to your office with the chief complaint of shortness of breath and ...